Mohawk Industries (MHK) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
25 Jul, 2025Executive summary
Q2 2025 net sales were $2.8B, flat year-over-year, with operational improvements, productivity gains, and cost containment actions supporting results amid challenging market conditions.
Adjusted EPS was $2.77, with net earnings down year-over-year due to higher input costs and lower sales volume, partially offset by restructuring and favorable FX.
Free cash flow was ~$125M; 393,000 shares repurchased for ~$42M; new $500M share repurchase authorization approved.
Restructuring actions are on track, targeting ~$100M in annual cost savings in 2025 through operational streamlining and technology investments.
Industry faces continued pricing pressure and soft demand, with commercial channels outperforming residential.
Financial highlights
Q2 2025 gross margin was 25.5% as reported, 26.4% adjusted, down year-over-year due to higher input costs and lower volume, partially offset by productivity and FX.
Adjusted operating income was $223M (8.0% margin), down from $257M (9.2%) prior year.
Adjusted EBITDA for Q2 2025 was $371M (13.3% margin), down from $406M (14.5%) prior year.
Cash and equivalents at $547M as of June 28, 2025; net debt at $1.65B; net debt to adjusted EBITDA at 1.2x.
Q2 CapEx was $80M; 2025 CapEx projection reduced to ~$500M, focused on cost reduction and innovation.
Outlook and guidance
Q3 2025 adjusted EPS expected between $2.56 and $2.66, excluding restructuring or one-time charges.
Fourth quarter results anticipated to improve year-over-year, driven by easing inflation, price increases, stronger mix, and restructuring benefits.
Guidance does not include potential impact from new tariffs, which remain uncertain.
Restructuring actions expected to deliver ~$100M in cost savings for 2025; additional $10M annual savings from new actions at a $20M cost.
Full-year tax rate forecasted at approximately 19%.
Latest events from Mohawk Industries
- Q4 2025 net sales rose 2.4% to $2.7B; 2026 outlook expects improved sales and earnings.MHK
Q4 202527 Feb 2026 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 202418 Jan 2026 - Q1 2025 sales fell 5.7% to $2.53B; adjusted EPS $1.52; tariffs add $50M in costs.MHK
Q1 202525 Dec 2025 - Adjusted EPS steady at $1.95 as cost actions offset weak demand; $285M savings targeted.MHK
Q4 20249 Dec 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing1 Dec 2025 - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 202524 Oct 2025